Does TOFACITINIB Cause Chondropathy? 64 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Chondropathy have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.0% of all adverse event reports for TOFACITINIB.
64
Reports of Chondropathy with TOFACITINIB
0.0%
of all TOFACITINIB reports
0
Deaths
13
Hospitalizations
How Dangerous Is Chondropathy From TOFACITINIB?
Of the 64 reports, 13 (20.3%) required hospitalization, and 1 (1.6%) were considered life-threatening.
Is Chondropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 64 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Chondropathy?
ADALIMUMAB (524)
ETANERCEPT (332)
METHOTREXATE (153)
ABATACEPT (140)
RITUXIMAB (126)
LEFLUNOMIDE (119)
INFLIXIMAB (107)
TOCILIZUMAB (52)
SECUKINUMAB (49)
CIPROFLOXACIN (45)
Which TOFACITINIB Alternatives Have Lower Chondropathy Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN